Mohammed A. Aljama

Stem Cell Transplantation for Light Chain Amyloidosis: Decreased Early Mortality Over Time

M Hasib Sidiqi, Mohammed A. Aljama, Francis K. Buadi et al. · Journal of Clinical Oncology · 2018 · 128 citations

Medicine, Surgery, Cell Therapy +10

Venetoclax for the treatment of translocation (11;14) AL amyloidosis

M Hasib Sidiqi, Abdullah S. Al Saleh, Nelson Leung et al. · Blood Cancer Journal · 2020 · 54 citations · Full text

Medicine, Pathology, Molecular Pathology +3

Association of dose escalation of octreotide long‐acting release on clinical symptoms and tumor markers and response among patients with neuroendocrine tumors

K Al-Efraij, Mohammed A. Aljama, Hagen F. Kennecke · Cancer Medicine · 2015 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

Plasma cell proliferative index is an independent predictor of progression in smoldering multiple myeloma

Mohammed A. Aljama, M Hasib Sidiqi, Arjun Lakshman et al. · Blood Advances · 2018 · 31 citations · Full text

Medicine, Hematology, Oncology +14

Light chain type predicts organ involvement and survival in AL amyloidosis patients receiving stem cell transplantation

M Hasib Sidiqi, Mohammed A. Aljama, Eli Muchtar et al. · Blood Advances · 2018 · 27 citations · Full text

Medicine, Nephrology, Pathology +16